Clinical Trials Browser

Phase 2 × Acneiform Eruptions × 1 year × Clear all

NCT04697069 2025-09-22

A Study to Evaluate of the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Acneiform Rash

Phase 2 Terminated

4 enrolled 7 charts

Acneiform Eruptions